Pérez de la Cruz, G.; Pérez de la Cruz, V.; Navarro Cossio, J.; Vázquez Cervantes, G.I.; Salazar, A.; Orozco Morales, M.; Pineda, B.
Kynureninase Promotes Immunosuppression and Predicts Survival in Glioma Patients: In Silico Data Analyses of the Chinese Glioma Genome Atlas (CGGA) and of the Cancer Genome Atlas (TCGA). Pharmaceuticals 2023, 16, 369.
https://doi.org/10.3390/ph16030369
AMA Style
Pérez de la Cruz G, Pérez de la Cruz V, Navarro Cossio J, Vázquez Cervantes GI, Salazar A, Orozco Morales M, Pineda B.
Kynureninase Promotes Immunosuppression and Predicts Survival in Glioma Patients: In Silico Data Analyses of the Chinese Glioma Genome Atlas (CGGA) and of the Cancer Genome Atlas (TCGA). Pharmaceuticals. 2023; 16(3):369.
https://doi.org/10.3390/ph16030369
Chicago/Turabian Style
Pérez de la Cruz, Gonzalo, Verónica Pérez de la Cruz, Javier Navarro Cossio, Gustavo Ignacio Vázquez Cervantes, Aleli Salazar, Mario Orozco Morales, and Benjamin Pineda.
2023. "Kynureninase Promotes Immunosuppression and Predicts Survival in Glioma Patients: In Silico Data Analyses of the Chinese Glioma Genome Atlas (CGGA) and of the Cancer Genome Atlas (TCGA)" Pharmaceuticals 16, no. 3: 369.
https://doi.org/10.3390/ph16030369
APA Style
Pérez de la Cruz, G., Pérez de la Cruz, V., Navarro Cossio, J., Vázquez Cervantes, G. I., Salazar, A., Orozco Morales, M., & Pineda, B.
(2023). Kynureninase Promotes Immunosuppression and Predicts Survival in Glioma Patients: In Silico Data Analyses of the Chinese Glioma Genome Atlas (CGGA) and of the Cancer Genome Atlas (TCGA). Pharmaceuticals, 16(3), 369.
https://doi.org/10.3390/ph16030369